Mutual Of America Capital Management LLC Agios Pharmaceuticals, Inc. Transaction History

Mutual Of America Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$34.45 - $53.48 $25,837 - $40,110	-750 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$46.17 - $68.1 $1.13 Million - $1.67 Million	-24,482 Reduced 97.03%	750 $37,000
Q1 2019 May 13, 2019	BUY	$45.92 - $67.67 $38,526 - $56,775	839 Added 3.44%	25,232 $1.7 Million
Q3 2018 Nov 13, 2018	SELL	$71.67 - $91.95 $11,753 - $15,079	-164 Reduced 0.67%	24,393 $1.88 Million
Q2 2018 Aug 09, 2018	SELL	$73.22 - $99.55 $193,886 - $263,608	-2,648 Reduced 9.73%	24,557 $2.07 Million
Q1 2018 May 11, 2018	SELL	$59.83 - $86.53 $201,148 - $290,913	-3,362 Reduced 11.0%	27,205 $2.23 Million
Q4 2017 Jan 31, 2018	BUY	$52.12 - $72.33 $10,997 - $15,261	211 Added 0.7%	30,567 $1.75 Million
Q3 2017 Oct 18, 2017	BUY	$54.89 - $67.12 $1.67 Million - $2.04 Million	30,356	30,356 $2.03 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.26B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.